Jabco Pharma is the dedicated pharmaceutical consulting division of Jabco Global, a US-based advisory platform delivering high-level strategic, technical, and regulatory support across the full product lifecycle—from early formulation to commercial manufacturing and global regulatory approval.
Through Jabco Pharma, we provide specialized expertise to pharmaceutical companies, CDMOs, and investors, helping solve complex challenges in development, CMC, GMP, and regulatory strategy.
Our capabilities cover formulation development, process optimization, quality systems, and regulatory pathways across a wide range of dosage forms including oral solids, injectables, topicals, and advanced drug delivery systems.
The division is led by Dr. Hashim Ahmed (BPharm, PhD, WHO Fellow), who brings over 35 years of global pharmaceutical experience across leading organizations such as Roche, GSK, and Johnson & Johnson. He has contributed to the development and commercialization of multiple products and is an inventor of 20+ patents in drug delivery and formulation technologies.
Jabco Pharma operates as a focused center of excellence within Jabco Global—delivering science-driven, practical solutions that bridge innovation and commercial success.


